Back to Blog
Status of isonics corp6/15/2023 These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. In addition, as of May 23, 2005, a subsidiary of Trilogy has warrants to purchase from a non-affiliate shareholder of this company 100,000 shares of common stock for $1.35 per share.Įxcept for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Isonics Corporation pays Trilogy an aggregate of $125,000 for the period April through September 2005. In addition, Trilogy Capital Partners and its affiliates may own securities of the presenting companies, and may from time to time purchase and sell securities of these companies in the open market or in private transactions. The companies presented by are usually clients of Trilogy Capital Partners and compensate Trilogy Capital Partners for these services, including cash compensation and equity securities. Trilogy Capital Partners provides investor relations services to public companies. is a wholly-owned subsidiary of Trilogy Capital Partners, Inc. Resources available on include audio interviews with corporate leaders and respected commentators, as well as technical white papers and other forms of market and investment analysis. The primary mission of is to provide informed investors with information and commentary about investment growth opportunities within the homeland security industry. provides exclusive commentary, research, interviews and other information focused on the fast-growing global homeland security marketplace. A video demonstrating the functioning NeutroTest prototype can be viewed at. A presentation about Isonics' NeutroTest(tm) explosive detection prototype can be found at. Additional information may be obtained at the Company's Web site at. Our efforts in the Homeland Security segment are nascent at the present time as we proceed to develop further our neutron-based detection technologies. This high degree of purification provides enhanced properties as compared to natural materials. Stable isotopes can be thought of as ultra pure materials. Isonics' Life Sciences division markets and sells isotopes to the health care industry for the imaging and treatment of cancer. Isonics is a world leader in isotopically engineered materials and through its semiconductor division produces isotopically pure silicon-28 chemicals and wafers for the semiconductor industry. Isonics Corporation has three business divisions: (1) Isonics Semiconductor, (2) Isonics Life Sciences, and (3) Homeland Security and Defense. The interview is available free of charge to interested investors. He also discusses the intended acquisition of IUT-Berlin, the Company's longtime technology development partner on the NeutroTest(tm) explosive detection device and other initiatives. Among the topics covered is the recent Isonics acquisition of Protection Plus Security Consultants. Rubizhevsky discusses Isonics' strategy for the creation of a multi-dimensional Homeland Security division through acquisitions of complementary technologies and cash-positive companies. Isonics, committed to the development of next-generation technology for the homeland security and semiconductor markets, is a technology innovator developing a number of proprietary technologies and services for the global homeland security sector. LOS ANGELES, (PRIMEZONE) -, the online source for expert information on high-growth investing in the multi-billion dollar Homeland Security marketplace, has announced the availability of an interview with Boris Rubizhevsky, President of the Homeland Security division of Isonics Corporation, (Nasdaq:ISON).
0 Comments
Read More
Leave a Reply. |